| Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) | 
|---|
| 01/21/1999 | WO1999002674A1 Peptides containing the motif igd and their use as cell migration modulators | 
| 01/21/1999 | WO1999002552A2 Chimeric interleukin-6 soluble receptor/ligand protein, analogs thereof and uses thereof | 
| 01/21/1999 | WO1999002547A1 Cytokine-, stress-, and oncoprotein-activated human protein kinase kinases | 
| 01/21/1999 | WO1999002519A1 4,5-DIHYDRO-[1H]-BENZ[g]INDAZOLE-3-CARBOXYLIC ACID DERIVATIVES | 
| 01/21/1999 | WO1999002517A1 6-pyrrolidin-2-ylpyrindine derivatives, their preparation and application in therapy | 
| 01/21/1999 | WO1999002496A1 (+)-norcisapride useful for 5-ht3 and 5-ht4 mediated disorders | 
| 01/21/1999 | WO1999002494A1 Gastrokinetic monocyclic benzamides of 3- or 4-substituted 4-(aminomethyl)-piperidine derivatives | 
| 01/21/1999 | WO1999002252A1 Improvements in or relating to capsules | 
| 01/21/1999 | WO1999002156A1 Gastrokinetic bicyclic benzamides of 3- or 4-substituted 4-(aminomethyl)-piperidine derivates | 
| 01/21/1999 | WO1999002144A1 Anion regulator for ruminants | 
| 01/21/1999 | CA2296037A1 4,5-dihydro-¬1h|-benz¬g|indazole-3-carboxylic acid derivatives | 
| 01/21/1999 | CA2295666A1 6-pyrrolidin-2-ylpyrindine derivatives, their preparation and application in therapy | 
| 01/21/1999 | CA2294757A1 Anion regulator for ruminants | 
| 01/21/1999 | CA2292480A1 (+)-norcisapride useful for 5-ht3 and 5-ht4 mediated disorders | 
| 01/20/1999 | EP0892063A2 Histidine kinase | 
| 01/20/1999 | EP0892062A2 The Chlamydia trachomatis Glutamyl-tRNAGln amidotransferase subunit ratC | 
| 01/20/1999 | EP0892057A2 Response regulator | 
| 01/20/1999 | EP0892051A2 CDNA Clone heoad54 that encodes a human 7 transmembrane receptor | 
| 01/20/1999 | EP0891978A2 5H-Thiazolo (3,2-a) pyrimidine derivatives | 
| 01/20/1999 | EP0891776A1 Simethicone/anhydrous calcium phosphate compositions | 
| 01/20/1999 | EP0891375A1 Peptidyl compounds having mmp and tnf- liberation inhibitory activity | 
| 01/20/1999 | EP0891363A1 Heterocyclic compounds and their preparation and use | 
| 01/20/1999 | EP0891362A1 Pyrrolopyrrolone derivatives as inhibitors of neutrophil elastase | 
| 01/20/1999 | EP0891355A1 Inhibitors of farnesyl-protein transferase | 
| 01/20/1999 | EP0891353A1 Inhibitors of farnesyl-protein transferase | 
| 01/20/1999 | EP0891335A1 Inhibitors of farnesyl-protein transferase | 
| 01/20/1999 | EP0891332A1 6-phenylpyridyl-2-amine derivatives | 
| 01/20/1999 | EP0891329A1 Peptidyl compounds having mmp and tnf inhibitory activity | 
| 01/20/1999 | EP0891328A1 Peptidyl compounds having mmp and tnf inhibitory activity | 
| 01/20/1999 | EP0891189A1 Medicament for optimising mucosal viscosity and stimulating intestinal function | 
| 01/20/1999 | EP0891187A1 Use of derivatives of tetrahydro-beta-carbolines as antimetastatic agents | 
| 01/20/1999 | EP0891186A1 Nasal administration of agents for treatment of delayed onset emesis | 
| 01/20/1999 | EP0693053B1 Urea and amide derivatives and their use in the control of cell membrane potassium channels | 
| 01/20/1999 | EP0674624B1 Pyrazoles having crf antagonist activity | 
| 01/20/1999 | EP0630245B1 Protein kinase c inhibitor | 
| 01/20/1999 | CN1205704A 2,7-substituted octahydro-pyrrolo (1,2-A) pyrazine derivatives | 
| 01/20/1999 | CN1205699A 1-(1,2-disubstituted piperidinyl)-4-substituted piperazine derivatives | 
| 01/20/1999 | CN1205335A Tricyclic diazepine vasopression antagonists | 
| 01/19/1999 | US5861518 Phthalide compounds and their production process | 
| 01/19/1999 | US5861510 Antiarthritic agents, antiulcer agents, restenosis, oral diseases | 
| 01/19/1999 | US5861436 Inhibitors of the relese of tumor necrosis factor | 
| 01/19/1999 | US5861425 Indole-ethanamines | 
| 01/19/1999 | US5861418 Aminobenzoic acid derivatives | 
| 01/19/1999 | US5861412 Dihydro-isoquinoline compounds and their use as pharmaceuticals | 
| 01/19/1999 | US5861402 1,4-dihydropyridine compounds | 
| 01/19/1999 | US5861401 Treatment of congestive heart failure | 
| 01/19/1999 | US5861394 Use of N-substituted phenothiazines | 
| 01/19/1999 | US5861313 Method of isolating bile duct progenitor cells | 
| 01/19/1999 | US5861048 Dissolving aa alkaline earth metal or iron with a phosphorylated saccharide or one bound to a protein or peptide for use in feeds, fertilizers, foods beverages or tablets | 
| 01/19/1999 | CA2166902C 3-amidopyrazole derivatives, process for preparing these and pharmaceutical compositions containing them | 
| 01/19/1999 | CA2108455C Pharmaceutical compositions against gastric disorders | 
| 01/19/1999 | CA2037663C Use of complexes and chelates resp., of antibiotics with bivalent and/or trivalent metals in the obtaining of anti-ulcer drugs, new complexes and chelates resp., of antibiotics with bivalent and/trivalent metals and processes for the obtaining thereof | 
| 01/18/1999 | CA2237050A1 Histidine kinase | 
| 01/18/1999 | CA2237043A1 Response regulator | 
| 01/14/1999 | WO1999001582A1 Screening methods using an atpase protein from a virus of the flaviviridae family | 
| 01/14/1999 | WO1999001553A1 Murine and human cerberus-like proteins and compositions comprising them | 
| 01/14/1999 | WO1999001467A2 Therapeutically active compounds with low systemic activity due to reduce half life | 
| 01/14/1999 | WO1999001454A1 Imidazopyrimidines and imidazopyridines for the treatment of neurological disorders | 
| 01/14/1999 | WO1999001452A1 Novel cycloalkyl substituted imidazoles | 
| 01/14/1999 | WO1999001451A1 Azetidinylpropylpiperidine derivatives, intermediates and use as tachykinin antagonists | 
| 01/14/1999 | WO1999001444A1 Polymorphic form of the tachykinin receptor antagonist 2-(r)-(1-(r) -(3,5-bis(trifluoromethyl) phenyl)ethoxy)-3-(s)-(4-fluoro) phenyl-4-(3-5 (-oxo-1h,4h-1,2,4,-triazolo) methylmorpholine | 
| 01/14/1999 | WO1999001439A1 Aryl-and arylamino-substituted heterocycles as corticotropin releasing hormone antagonists | 
| 01/14/1999 | WO1999001416A2 1-amino-alkylcyclohexane nmda receptor antagonists | 
| 01/14/1999 | WO1999001164A1 Cloning pigs using donor nuclei from differentiated cells | 
| 01/14/1999 | WO1999001149A1 Health supplement | 
| 01/14/1999 | WO1999001136A1 Novel substituted imidazole compounds | 
| 01/14/1999 | WO1999001131A1 Novel substituted imidazole compounds | 
| 01/14/1999 | WO1999001130A1 Novel substituted imidazole compounds | 
| 01/14/1999 | WO1999001112A1 Multiple unit effervescent dosage form | 
| 01/14/1999 | WO1999001110A1 Targeted liposomal constructs for diagnostic and therapeutic uses | 
| 01/14/1999 | WO1998040097A3 Bovine respiratory and enteric coronavirus as a vaccine | 
| 01/14/1999 | CA2297791A1 Health supplement | 
| 01/14/1999 | CA2296014A1 Aryl-and arylamino-substituted heterocycles as corticotropin releasing hormone antagonists | 
| 01/14/1999 | CA2295762A1 Novel cycloalkyl substituted imidazoles | 
| 01/14/1999 | CA2295294A1 Cloning pigs using donor nuclei from differentiated cells | 
| 01/14/1999 | CA2295228A1 Novel substituted imidazole compounds | 
| 01/14/1999 | CA2294900A1 Targeted liposomal constructs for diagnostic and therapeutic uses | 
| 01/14/1999 | CA2294524A1 Novel substituted imidazole compounds | 
| 01/14/1999 | CA2294522A1 Novel substituted imidazole compounds | 
| 01/14/1999 | CA2294193A1 Azetidinylpropylpiperidine derivatives, intermediates and use as tachykinin antagonists | 
| 01/14/1999 | CA2294117A1 Imidazopyrimidines and imidazopyridines for the treatment of neurological disorders | 
| 01/14/1999 | CA2289453A1 Screening methods using an atpase protein from a virus of the flaviviridae family | 
| 01/14/1999 | CA2236489A1 Novel compounds | 
| 01/13/1999 | EP0889961A2 Monocyte chemotactic protein-5 materials and methods | 
| 01/13/1999 | EP0889902A1 Antibiotic peptides from bovine milk | 
| 01/13/1999 | EP0889894A1 Phosphoramidates and phosphinic amides, their use to modulate the activity of endothelin | 
| 01/13/1999 | EP0889888A1 Novel treatment for cns injuries | 
| 01/13/1999 | EP0889877A1 META-SUBSTITUTED PHENYLENE DERIVATIVES AND THEIR USE AS ALPHAvBETA3 INTEGRIN ANTAGONISTS OR INHIBITORS | 
| 01/13/1999 | EP0889732A1 Macrophage stimulating protein for the treatment of gastrointestinal disorders | 
| 01/13/1999 | EP0889729A1 Linseed drug | 
| 01/13/1999 | EP0889726A1 Novel cycloalkyl substituted imidazoles | 
| 01/13/1999 | EP0757670B1 Benzamide derivatives as vasopressin antagonists | 
| 01/13/1999 | CN1205010A Isoxazolidine derivatives | 
| 01/13/1999 | CN1205009A Pyrazolopyrimidines type compound | 
| 01/13/1999 | CN1205006A Substituted tetracyclic tetrahydrofuran derivatives | 
| 01/13/1999 | CN1204526A 'Huweiling' capsule- for protecting stomach | 
| 01/13/1999 | CN1204520A Medicine for treatment of lithiasis | 
| 01/13/1999 | CN1204515A Chinese medicinal preparation for treatment of toothache and method for preparation thereof | 
| 01/13/1999 | CN1204510A Stype using gossypol (and) its derivative as active component and use | 
| 01/13/1999 | CN1041631C Novel carbocyclic nucleoside agents useful as selective inhititors of proinflammatory cell factor |